![Kathleen Metters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Metters
Président chez
SYNTARA LIMITED
Profil
Kathleen M.
Metters currently works at Syntara Ltd., as Chairman from 2023, HemoShear Therapeutics, Inc., as Non-Executive Director from 2019, and Aslan Pharmaceuticals Ltd., as Independent Non-Executive Director from 2021.
Dr. Metters also formerly worked at Lycera Corp., as President, Chief Executive Officer & Director from 2011 to 2015, ASLAN Pharmaceuticals Pte Ltd., as Independent Director, Merck & Co., Inc., as SVP-External Discovery & Preclinical Sciences from 2009 to 2011, and Merck Frosst Canada Ltd., as Vice President.
Dr. Metters received her doctorate degree from Imperial College London and undergraduate degree from the University of Manchester Institute of Science & Technology.
Postes actifs de Kathleen Metters
| Sociétés | Poste | Début |
|---|---|---|
| SYNTARA LIMITED | Président | 03/10/2023 |
| ASLAN PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 18/03/2021 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Directeur/Membre du Conseil | 19/06/2019 |
Anciens postes connus de Kathleen Metters
| Sociétés | Poste | Fin |
|---|---|---|
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Directeur/Membre du Conseil | 17/07/2024 |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Directeur Général | 03/02/2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2011 |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Corporate Officer/Principal | - |
Formation de Kathleen Metters
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Syntara Ltd.
 Syntara Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceutical products for respiratory disorders | Health Technology |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Health Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
 University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Frosst Canada Ltd.
Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Health Technology |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Choisissez Zonebourse 
